Search page

Changes in IgG4 and IgE epitope binding profile are greater with sublingual than oral immunotherapy in milk-allergic children, and correspond to efficacy outcomes

Clinical remission of allergic rhinoconjunctivitis with a 300IR 5-grass pollen sublingual immunotherapy tablet

Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children

Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort

Cross-tolerance to cashew by prophylactic sublingual immunotherapy with different tree nuts in Brown Norway rats

Demystifying the fear of lack of adherence to sublingual immunotherapy (SLIT)

EFFECTIVENESS AND SAFETY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY WITH Pru p3 EXTRACT IN PATIENTS WITH LTP ALLERGY

Early Immunologic Parameters Predicting Response to Sublingual Immunotherapy in Allergic Rhinitis Patients

Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity

Effect of sublingual immunotherapy on allergic rhinitis: Real-life data analysis

Effectiveness of sublingual immunotherapy in patients with atopic dermatitis allergic to house dust mite: an open label extension study

Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR

Efficacy of 300IR house dust mite sublingual immunotherapy tablet on steroid sparing in patients with house dust mite allergic rhinitis: an in-depth analysis

Efficacy of Index of reactivity (IR) liquid sublingual immunotherapy in allergic rhinoconjunctivitis: A systematic review and meta-analysis of randomised studies

Efficacy of a sublingual bacterial extract in the production of gamma interferon and its correlation with the prevention of recurrent acute respiratory infections in pediatrics

Efficacy of sublingual immunotherapy in children with allergic rhinitis

Eosinophilic Esophagitis Induced by Sublingual Immunotherapy (SLIT): A Rare but Emerging Side Effect

Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study

Evaluation of patients’ expectation and benefits of sublingual Named-Patient Products in the treatment of allergic respiratory diseases: the French ERAPP prospective cohort study

Evaluation of the efficacy, adverse effects, and cost-effectiveness of sublingual immunotherapy with dominant allergens for allergic rhinitis due to respiratory allergens in adults and children

Evaluation of total Immunoglobulin D in sublingual immunotherapy for allergic rhinitis

Exacerbation of eosinophilic esophagitis in a child with seasonal allergic rhinitis during sublingual immunotherapy

Factors Influencing Adherence to House Dust Mite Sublingual Immunotherapy in Allergic Rhinitis Patients

Good patient adherence to sublingual immunotherapy for allergic rhinitis can be achieved, when ENT-physicians collaborate with pharmacies in a straightforward adherence programme

Health Economic Evaluation of 5-Grass Pollen Sublingual ImmunotherapyTablets for Grass Pollen-Induced Allergic Rhinitis in Finland, Norway and Sweden

House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents

House dust mite sublingual immunotherapy is effective in generating functional blocking antibodies IgA1 and IgA2: RDBPC Phase II/III studies of Japanese and European Cohorts

Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset

Impact of allergic rhinitis activity on the effect of 300IR house dust mite sublingual immunotherapy tablet in adolescent patients

Impact of different prophylactic sublingual immunotherapy regimes on peanut allergy prevention in Brown Norway rats

Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study

Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study

Long-term post treatment benefits of house dust mites sublingual immunotherapy in polysensitized children

Modulation of allergen-specific type 2 memory B cells over the course of 18 months sublingual immunotherapy for house dust mite allergy

Optimization of the administration of liquid sublingual immunotherapy (SLIT) treatments using iPUMP®: The SPEED study, a “Real Life” study

Positive effect of a 300IR dosing pump-administered liquid sublingual immunotherapy on allergic disease evolution: Results from the observational, prospective, longitudinal PRACTIS study

Profile of patients treated with the 300IR liquid sublingual immunotherapy for cat allergy and perception of treatment effect: Results from a French survey

Prospective, pilot, phase 1 study of iPUMP© in patients starting sublingual allergen immunotherapy (Staloral©)

Randomized Controlled Trial of Sublingual Immunotherapy for Egg Allergy

Real life effectiveness and safety of sublingual immunotherapy with aeroallergens. A retrospective study

Real world data on persistence and compliance with sublingual allergen specific immunotherapy, a Dutch experience

Real-life Non-interventional Post authorization Safety Study with the SQ tree sublingual immunotherapy tablet

Relevant patient benefit in the short-term with a 300IR dosing pump-administered liquid sublingual immunotherapy: Results from the observational, prospective, longitudinal PRACTIS study

Renewal’s analysis of liquid sublingual immunotherapy (SLIT) treatments using iPUMP: SPEED study, a Real-Life study

Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes

Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study

SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma

Safety Profile and Clinical Outcome of Sublingual Immunotherapy (SLIT) with Pru p 3 in Patients with LTP Allergy Undergoing Food Reintroduction

Safety and compliance of sublingual immunotherapy with house dust mite extract in patients with atopic dermatitis for 1 year

Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review

Safety of 300IR liquid sublingual immunotherapy of cat allergen extract for respiratory allergy to cat dander: a post-marketing experience

Safety profile in clinical trials of sublingual immunotherapy with carbamylated monomeric allergoid

Short-term benefits of sublingual immunotherapy in routine clinical practice: Patient Benefit Index by class in the observational, prospective, longitudinal study PRACTIS

Short-term benefits of sublingual immunotherapy in routine clinical practice: deciphering factors influencing the patient satisfaction in the observational, prospective, longitudinal study PRACTIS

Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in mite allergic rhinitis patients with concomitant asthma

Steroid sparing effect of liquid sublingual immunotherapy in patients with allergic rhinitis with or without asthma in the real-world EfficAPSI study

Subcutaneous allergen-specific immunotherapies for inhalation allergens induce higher levels of therapy specific IgG4 antibodies than sublingual therapies: a retrospective data analysis

Sublingual allergen immunotherapy in children with AR

Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis

Sublingual immunotherapy for house dust mite allergy induces expansions of allergen-specific memory B cells expressing CD29 and downregulating IL4Rα

Sublingual immunotherapy with Pru p 3 induces DNA methylation changes towards tolerance in dendritic cells from patients with nsLTP allergy

Sublingual immunotherapy with peanut protein extract has an effect in Brown Norway rats sensitised via the skin

Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens

Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in pediatric patients with allergic rhinitis due to house dust mites or pollens

Sympout study: Evolution of clinical parameters in a pediatric population allergic to pollens or house dust mites treated with sublingual immunotherapy in liquid formulation standardized in TBU/ml

Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml

TARC levels in patients with atopic dermatitis: a marker for clinical improvement following sublingual immunotherapy?

The 300 IR house dust mite sublingual tablet is effective and well tolerated in patients with allergic rhinoconjunctivitis and concomitant allergic asthma in a real-world data setting

The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis

Treatment with the 300 IR house dust mite sublingual tablet is safe and well tolerated in adults and adolescents in a real-world data setting – results of a non-interventional post authorization safety study

Where are we currently in sublingual immunotherapy for food allergy?

Welcome

Only match titles

What are you looking for?

Website

Only match titles

What are you looking for?

Website

Sessions